medline.ch Respirationstrakt Interstitielle Pneumopathien

	Study on the anti- pulmonary fibrosis mechanism of Renshen Pingfei formula by inhibiting M2 macrophage polarization and regulating TGF - Î²/SMAD signaling pathway. J Ethnopharmacol Hong L, Sun Y, Hou H, Zhang J, Shi W, Yang Y, Fan X, Zhu J. PMID: 41780616 [PubMed - as supplied by publisher]
	Economic Burden of Idiopathic Pulmonary Fibrosis: Updated Evidence on Costs and Resource Use. Pharmacoeconomics Diamantopoulos A, Pople O, Godman A, Papastergios E. PMID: 41774348 [PubMed - as supplied by publisher]
	Magnesium sulphate for treating acute bronchiolitis in children under two years of age. Cochrane Database Syst Rev Chandelia S, Kumar D, Tandon D, Makol J. PMID: 41773552 [PubMed - in process]
	Research Progress on the Mechanisms of Gut Microbiota Dysbiosis Associated With Idiopathic Pulmonary Fibrosis: A Review. Cureus Li X, Xu S, Li Y, Wang R, Qin C, Wang X. PMID: 41769611 [PubMed]
	Ambulatory oxygen for treatment of exertional hypoxaemia in pulmonary fibrosis (PFOX): a multicentre, randomised, sham-controlled trial. Lancet Respir Med Holland AE, Hoffman M, Corte TJ, Chambers DC, Hepworth G, Ekström MP, Glaspole I, Goh NS, Khor YH, Palmer AJ, Barton C, Cox I, Dowman L, Einarsson J, Fuhrmeister L, Mackintosh JA, Neglén P, Prasad JD, Bucciarelli J, Scherp S, Sköld M, Smallwood N, Symons K, Thompson M, McDonald CF. PMID: 41765033 [PubMed - as supplied by publisher]
	Cx3cr1 depletion ameliorates lipid metabolic dysregulation and pulmonary fibrosis induced by silica. Chem Biol Interact Hu E, Wang Y, Li Z, Zhang J, Huang W, Shen J, Liu D, Zhu Z, Tian L, Wang Y. PMID: 41763510 [PubMed - as supplied by publisher]
	Effects of Nutritional Support Combined With Respiratory Training on Pulmonary Function in Patients With Obliterative Bronchiolitis: A Propensity Score Matching Study. Br J Hosp Med (Lond) Chen Y, Chen Y, Yuan X, Qian D, Hu X. PMID: 41762089 [PubMed - in process]
	Idiopathic Pulmonary Fibrosis: An Overview. Br J Hosp Med (Lond) May J, Jenkins G. PMID: 41762087 [PubMed - in process]
	Impact of a national nirsevimab programme on critical care transport of babies with bronchiolitis: a retrospective observational study. Arch Dis Child Moore T, Afridi A, Aminudin NH, Gibbons C, Grant O, Fucikova H, Moore CM. PMID: 41760138 [PubMed - as supplied by publisher]
	Viral Pathogens and Pulmonary Fibrosis: EMT-Driven Mechanisms and Insights From Traditional Chinese Medicine. Rev Med Virol Zang N, Wu Y, Li P, Liu Y, Wang S, Leng J, Zhan L, Lyu X, Pang L, Wang J. PMID: 41755466 [PubMed - in process]
	Inhalation-Based Nanoparticle Drug Delivery Targeting the Diseased Lower Airways in Idiopathic Pulmonary Fibrosis. Pharmaceutics Lee JW, Skibba M, Tang T, Noh H, Brasier AR, Hong S. PMID: 41754911 [PubMed]
	Incidence and Prevalence of Progressive Pulmonary Fibrosis (PPF): A Systematic Literature Review and Meta-analysis. Am J Med Sci Golchin N, Lesperance T, Scheuring J, Wan V, Hofer K, Collet JP, Patel A. PMID: 41747937 [PubMed - as supplied by publisher]
	Collagen-Based Delivery Systems for the Prevention of Alveolitis: A Narrative Review and Rationale for Biopharmaceutical Development Requirements. J Funct Biomater Darawsheh H, Shumkova MM, Buraya LM, Pomytkina MV, Pouya G, Bakieva F, Grin M, Bakhrushina EO, Kireeva N, Dydykin S, Vasil'ev Y. PMID: 41745554 [PubMed]
	Identification of a conserved sequence of disease progression in Idiopathic Pulmonary Fibrosis. Am J Respir Crit Care Med Huang X, Wu P, Guttentag AR, Quintana M, Kropski JA, Blackwell TS, Salisbury ML. PMID: 41738263 [PubMed - as supplied by publisher]
	Nerandomilast in idiopathic pulmonary fibrosis: data from the whole follow-up period of the FIBRONEER-IPF trial. Am J Respir Crit Care Med Oldham JM, Azuma A, Kreuter M, Maher TM, Martinez FJ, Richeldi L, Valenzuela C, Wijsenbeek MS, Liu Y, Zisa D, Zoz DF, Cottin V, FIBRONEER-IPF trial investigators. PMID: 41738262 [PubMed - as supplied by publisher]
	Shaping the landscape of interstitial lung disease in idiopathic inflammatory myopathies: state of the art, evidence gaps and a need for clinical trials. Clin Exp Rheumatol Rivero Gallegos D, Pais FM, Lan TY, Papadopoulou C, Joerns EK, Paul J, Rojas Serrano J, Kulkarni T, Gandiga PC, So H, Houghton K, Bagri N, Jansen M, Bader Meunier B, Wilfong EM, Aggarwal R, Hallowell RW, Nagaraja V. PMID: 41738254 [PubMed - indexed for MEDLINE]
	Circulating biomarkers in subjects with progressive pulmonary fibrosis: data from the INBUILD trial. ERJ Open Res Maher TM, Jenkins RG, Bonella F, Assassi S, Diefenbach C, Ittrich C, Rohr KB, Kolb M. PMID: 41736725 [PubMed]
	Emerging Therapies in Pulmonary Fibrosis. Pulm Ther Etchingham-Coll H, Temizel E, Okezie-Enyioma N, Martin N, Kaenmuang P, Coghlan S, Spagnolo P, Chaudhuri N. PMID: 41733797 [PubMed - as supplied by publisher]
	Radiologic Pattern of Fibrosis in Combined Pulmonary Fibrosis and Emphysema: Impact on Disease Trajectories and Prognostic Outcomes. Radiology Kim MS, Choe J, Hwang HJ, Kim HC, Chae EJ, Seo JB. PMID: 41733469 [PubMed - indexed for MEDLINE]
	Decoding tamoxifen on idiopathic pulmonary fibrosis: integrating network toxicology and multi-omics. Int J Surg Sun Y, Lu Z, Yu W, Huang S, Xie Y, Yao D, Wang H, Wu Q, Huang X, Li X. PMID: 41731859 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 39556

Seite 1 von 1978



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung